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Summary
 
In contrast to conventional T cells, natural killer (NK) 1.1
 
1
 
 T cell receptor (TCR)-
 
a
 
/
 
b
 
1
 
(NK1
 
1
 
T) cells, NK cells, and intestinal intraepithelial lymphocytes (IELs) bearing CD8-
 
a
 
/
 
a
 
chains constitutively express the interleukin (IL)-2 receptor (R)
 
b
 
/15R
 
b
 
 chain. Recent studies
have indicated that IL-2R
 
b
 
/15R
 
b
 
 chain is required for the development of these lymphocyte
subsets, outlining the importance of IL-15. In this study, we investigated the development of
these lymphocyte subsets in interferon regulatory factor 1–deficient (IRF-1
 
2
 
/
 
2
 
) mice. Surpris-
ingly, all of these lymphocyte subsets were severely reduced in IRF-1
 
2
 
/
 
2
 
 mice. Within CD8-
 
a
 
/
 
a
 
1
 
 intestinal IEL subset, TCR-
 
g
 
/
 
d
 
1
 
 cells and TCR-
 
a
 
/
 
b
 
1
 
 cells were equally affected by
IRF gene disruption. In contrast to intestinal TCR-
 
g
 
/
 
d
 
1
 
 cells, thymic TCR-
 
g
 
/
 
d
 
1
 
 cells devel-
oped normally in IRF-1
 
2
 
/
 
2
 
 mice. Northern blot analysis further revealed that the induction of
IL-15 messenger RNA was impaired in IRF-1
 
2
 
/
 
2
 
 bone marrow cells, and the recovery of
these lymphocyte subsets was observed when IRF-1
 
2
 
/
 
2
 
 cells were cultured with IL-15 in
vitro. These data indicate that IRF-1 regulates IL-15 gene expression, which may control the
development of NK1
 
1
 
T cells, NK cells, and CD8-
 
a
 
/
 
a
 
1
 
 IELs.
 
I
 
n addition to the conventional lymphocyte subsets, other
lineages have been identified as NK1.1
 
1
 
TCR-
 
a
 
/
 
b
 
1
 
(NK1
 
1
 
T) cells, NK cells, and intestinal intraepithelial lym-
phocytes (IELs). NK1
 
1
 
T cells have been recently classified
as a lymphocyte subset that shares common features with both
NK cells and conventional T cells. This lineage expresses NK
markers including NKR-P1, Ly-49, and IL-2R
 
b
 
/15R
 
b
 
 as
well as an invariant V
 
a
 
14J281TCR-
 
a
 
 chain in combina-
tion with V
 
b
 
8, V
 
b
 
7, or V
 
b
 
2 (1, 2). Expression of these
TCRs is required for NK1
 
1
 
 T cell development (3, 4). They
are positively selected by MHC class I–related CD1 or thymic
leukemia (TL) molecules (5–7). The majority of TCR-
 
a
 
/
 
b
 
1
 
or TCR-
 
g
 
/
 
d
 
1
 
 intestinal IEL expresses CD8-
 
a
 
/
 
a
 
 homodimers.
Both NK1
 
1
 
T cells and CD8-
 
a
 
/
 
a
 
1
 
 intestinal IELs can de-
velop through either extrathymic or alternative thymic path-
ways (1, 2, 8). Notably, the IL-2R
 
b
 
/15R
 
b
 
 chain is required
for the development of NK1
 
1
 
T cells, NK cells, and CD8-
 
a
 
/
 
a
 
1
 
 intestinal IELs (9, 10), and IL-15 preferentially pro-
motes the proliferation of these lymphocyte subsets (10–12).
IFN regulatory factor 1 (IRF-1), an IFN-inducible tran-
scriptional activator, was initially identified as a protein that
binds 
 
cis
 
-acting DNA elements in the IFN-
 
b
 
 promoter
(13–15) and the IFN-stimulated response element of IFN-
 
a
 
/
 
b
 
–stimulated genes (16, 17). Recent studies with IRF-
deficient (IRF-1
 
2
 
/
 
2
 
) mice demonstrated a reduction of
CD8
 
1
 
TCR-
 
a
 
/
 
b
 
1
 
 cells and decreased MHC class I levels
as a consequence of reduced expression of transporter asso-
ciated with antigen processing 1 (TAP-1) and low molecu-
lar weight protein 2 (LMP-2; 18, 19).
Since IRF-1 deficiency has been related to T cell matu-
ration, we examined the development of NK1
 
1
 
T cells, NK
cells, and IELs in IRF-1
 
2
 
/
 
2
 
 mice. Data indicated that these
lymphocyte subsets were selectively reduced and IL-15
messenger RNA (mRNA) was barely detectable in IRF-
1
 
2
 
/
 
2
 
 mice. Therefore, IRF-1 regulates the IL-15 gene that
is required for survival and/or expansion of these lympho-
cyte subsets in vivo.
 
Materials and Methods
 
Mice.
 
Mice deficient in IRF-1 (18) were backcrossed five
times with C57BL/6 mice. Homozygous IRF-1
 
2
 
/
 
2
 
 mice were
bred and identified by staining blood with anti-CD8 and -CD4
mAb. Wild-type or heterozygous mice were used as controls. All
mice were maintained in our animal facility according to institu-
tional guidelines, and experiments were done between 8 and 14 wk
of age.
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Cell Preparation and Culture.
 
Liver mononuclear cells (MNCs)
and IELs were prepared as previously described (20). In some ex-
periments, liver MNCs or IELs obtained from IRF-1
 
2
 
/
 
2
 
 mice
were cultured with 100 ng/ml mouse IL-15 (provided by Immu-
nex Co., Seattle, WA) for 7 d.
 
Antibodies and Flow Cytometric Analysis.
 
The following mAb
conjugates were purchased from PharMingen (San Diego, CA)
and used in this study: M1/69-FITC (anti-HSA), 53-5.8-FITC
(anti-CD8
 
b
 
), H57-597-FITC and -PE (anti–TCR-
 
b
 
), TM-
 
b
 
1-
PE (anti–IL-2R
 
b
 
), GL-3-PE (anti–TCR-
 
d
 
), 53-6.7-PE (anti-
CD8), PK136-PE and -biotin (anti-NK1.1), 1B1-PE (anti-CD1),
27D-biotin (anti–LFA-1), IM7-biotin (anti-CD44), and KJ16-bio-
tin (anti-V
 
b
 
8.1,8.2). B22-purified mAb (anti–H-2D
 
b
 
) was pre-
pared in our laboratory. Biotinylated mAbs were detected with
streptavidin red 670 (GIBCO BRL, Gaithersburg, MD) and puri-
fied mAbs were detected with goat anti–mouse IgG-FITC or
goat anti–rat IgM-FITC; 10
 
6
 
 cells were stained in 2% FCS PBS,
washed, and analyzed by FACScan
 
Ò using the Lysis II program
(Becton Dickinson, Mountain View, CA).
Analysis for IL-15 mRNA Expression. Bone marrow (BM) cells
were isolated and stimulated by 30 mg/ml LPS and 100 U/ml IFN-g
for 6 h. Total cellular RNA was isolated with TRIZOL (GIBCO
BRL) according to the manufacturer’s protocol. 10 mg of total
RNA were subjected to electrophoresis in a denaturing 1.0% aga-
rose gel containing 2% formaldehyde and transferred to Hybond
N1 nylon membrane (Amersham Corp., Arlington Heights, IL).
The filter was hybridized with mouse IL-15 cDNA probe radio-
actively labeled with [32P]dCTP. The mouse IL-15 cDNA used
as a probe was obtained by polymerase chain reaction using specific
primers: sense primer 59-GCC AGC TCA TCT TCA ACA-39 and
antisense primer 59-TAA GTC TGA GAC GAG CTC TTT-39.
Radioactivity was assessed using phosphorimager (Molecular Dy-
namics, Sunnyvale, CA). The filter was stripped and rehybridized
with a b-actin cDNA probe. 
Results and Discussion
Impaired NK11T Cell and NK Cell Development in IRF-
12/2 Mice. Mouse NK11T cells are generally either
CD4182 or CD4282 cells that are primarily found in the
thymus, liver, and BM (1, 2). We examined the NK11T
cell subset in mice deficient for IRF-12/2. Surprisingly, the
percentages of thymic and liver NK11T cells were de-
creased by 4–5 fold and 8–10 fold, respectively, in IRF-12/2
mice. The total number of thymic NK11T cells obtained
from IRF-12/2 mice was 10-fold lower than in wild-type
control mice. Interestingly, a partial reduction of NK11T
cells was also seen in IRF-11/2 mice (Fig. 1, Table 1). The
IL-2Rb/15Rb1TCR-a/b1 cells were also decreased, sug-
gesting that the pronounced reduction of NK11T cells de-
tected in IRF-12/2 mice was not simply due to the loss of
NK1.1 molecules from the cell surface (data not shown).
The small number of NK11T cells detected in IRF-12/2
mice expressed the IL-2Rb/15Rb chain and preferentially
expressed Vb81 TCR as seen in control mice (data not
shown). In addition, analysis of the thymus, liver, and
spleen using IRF-11/1, IRF-11/2, and IRF-12/2 mice
clearly demonstrated a reduction of NK cells (TCR-
b2NK1.11) in IRF-12/2 mice (Fig. 1). This is consistent
with the lack of NK cell function previously reported in
IRF-12/2 mice (21). Interestingly, IRF-11/2 mice consis-
tently showed an intermediate phenotype, reflecting the
dose-dependent requirement for genes regulated by IRF-1.
These analysis showed that IRF-1 is important for NK cell
and NK11T cell development.
Previous reports have shown that CD4281TCRa/b1
cells were selectively reduced in thymus and periphery of
IRF-12/2 mice (18). The data demonstrated a crucial role
for IRF-1 in T cell development for the first time. A recent
paper suggested that IRF-1 controls MHC class I expres-
sion through the regulation of transporter associated with
antigen 1 and low molecular weight protein (19). Since
mouse NK11T cells require b2-microgloblin–associated
CD1 and TL molecules for development (5–7, 20, 22, 23),
Table 1. Impaired Maturation of Thymic NK11T Cells in IRF-
12/2 Mice
Mice
Total
thymocytes
(3 106)
HSA2
cell
NK11T
cell
Total NK11T
cell
(3 104)
%%
IRF-11/1 81.7 6 4.7 3.4 6 0.4 11.9 6 1.4 39.5 6 8.8
IRF-11/2 87.3 6 10.8 3.2 6 0.6 8.1 6 0.6 22.6 6 7.5
IRF-12/2 86.0 6 11.8 1.6 6 0.4 2.4 6 0.4 3.3 6 0.6
Four to six mice from each group were individually analyzed. Thy-
mocytes were stained with M1/69-FITC (anti-HSA), H57-PE (anti–
TCR-b), and PK136-biotin (anti-NK1.1) plus streptavidin 670. The
percentage of NK11T cells was calculated in the HSA2 thymocyte
population.
Figure 1. IRF-1 is important for NK11T cell and NK cell maturation.
Thymocytes, liver, and spleen MNCs from indicated strains were stained
with M1/69-FITC (anti-HSA), H57-597-PE (anti–TCR-b), and
PK136-biotin (anti-NK1.1) plus streptavidin 670. HSA2 cells are shown.969 Ohteki et al. Brief Definitive Report
we examined CD1 expression on thymocytes from IRF-
12/2 mice. Consistent with a recent paper (19), Fig. 2
showed that the lack of the IRF-1 gene clearly resulted in
reduced H-2Db expression. However, the mean intensities
of CD1 on IRF-12/2 thymocytes was comparable to litter-
mate controls, suggesting that the IRF-1 gene does not
control NK11T cell development through CD1 expres-
sion. In addition, we can further exclude the role of the TL
antigen in NK11T cell development, since both IRF-12/2
and control mice are of the C57B1/6 background and do
not express TL.
Maturation of Intestinal IELs Is Reduced in IRF-12/2
Mice. The majority of IELs express CD8 and can be di-
vided into two subsets. One population bears CD8-a/b1
heterodimers and expresses TCR-a/b1, whereas the other
expresses CD8-a/a1 homodimers consisting of TCR-a/b1
and TCR-g/d1 cells. Using thymectomized recombinase
activating gene (RAG)-deficient mice reconstituted with
BM cells from athymic (nude) mice, thymus-independent
development of CD8-a/a1 IELs has been clearly demon-
strated to occur (8). Surprisingly, in IRF-12/2 mice, the
percentage of intestinal CD8-a/a1 IELs was approxi-
mately eight- to ninefold less than in wild-type control
mice. As seen with NK11T cells, mice heterozygous for
IRF-11/2 showed altered CD8-a/a1 IEL development.
TCR-g/d1 IELs were profoundly reduced by IRF gene
disruption (Fig. 3 A, Table 2). In addition, CD8-a/b1T
cells were also reduced as seen in periphery. The total cell
numbers of IELs from IRF-12/2 mice (0.4 6 0.1 3 106)
were three- to fourfold lower than those from littermate
controls (1.5 6 0.3 3 106). Therefore, IRF-1 controls the
expression of genes important for IEL T cell development.
It is likely that the reduced development of intestinal g/
d1T cells is controlled by other mechanisms unrelated to
MHC class I expression in IRF-12/2 mice. Previous studies
using b2-microglobulin–deficient (MHC class I2/2) mice
showed a reduction in TCR-a/b1 IELs, but not TCR-g/
d1 IELs (24), demonstrating that TCR-a/b1 and TCR-g/
d1 IELs have differential requirements for b2-microglobu-
lin dependent selection.
Since the majority of thymus-independent intestinal
TCR-g/d1 cells were absent in IRF-12/2 mice, we also
examined whether thymic TCR-g/d1 cells were present in
these mice. Although the number of intestinal TCR-g/d1
cells were decreased by 10-fold in IRF-12/2 mice, thymic
TCR-g/d1 cells were normal (Fig. 3 B, Table 2). Thus,
IRF-1 selectively affected the development of intestinal
TCR-g/d1 cells.
IL-15 mRNA Expression Is Impaired in IRF-12/2 BM
Cells. As certain cytokines are crucial for lymphocyte de-
velopment, it is possible that a reduction in the expression
of cytokine receptors or cytokines may result in poor selec-
tion, survival, or expansion of NK11T cells, NK cells, and
Figure 2. Normal CD1 expression on IRF-12/2 thymocytes. Thy-
mocytes from the indicated strains were stained with 1B1-FITC (anti-
CD1), 57.6.7-PE (anti-CD8), and L3T4-biotin (anti-CD4) plus streptavi-
din 670, and double-positive CD4181 thymocytes were analyzed for
CD1 expression. For H-2Db expression, total thymocytes were stained
with B22 (anti–H-2Db) plus goat anti–mouse Ig-FITC.
Figure 3. IRF-1 controls intestinal IEL development. (A) Intestinal
IELs were obtained from either IRF-11/1 mice, IRF-11/2 mice, or IRF-
12/2 mice and stained with H57-597 (anti–TCR-b) and GL-3-PE (anti–
TCR-d), or 53.6.7-FITC (anti–CD8a) and Lyt3-PE (anti-CD8b). (B)
Thymocytes were stained with L3T4-FITC (anti-CD4), GL-3-PE (anti–
TCR-d), and 53.6.7-FITC (anti-CD8a). Histograms are gated on dou-
ble-negative CD4282 thymocytes and TCR-d expression is shown.970 IRF-1 Regulates IL-15–mediated Lymphocyte Maturation
intestinal IEL subsets in IRF-12/2 mice. IL-15 is one of the
most likely targets because NK11T cells, NK cells and in-
testinal IEL subsets are severely reduced in IL-2Rb/
15Rb2/2 mice (9, 10), while present in normal numbers in
IL-2, IL-7Ra, or IL-7–deficient mice (10, 25–27). Inter-
estingly, IL-15 preferentially promotes the proliferation of
these T cell subsets (10–12). Thus, we examined IL-15
mRNA expression by Northern blot analysis (Fig. 4 A).
Wild-type BM cells cultured in the presence of LPS and
IFN-g for 6 h, clearly increased IL-15 mRNA levels. In
contrast, IL-15 mRNA remained undetectable in IRF-12/2
BM cells, even after induction with LPS and IFN-g. These
data demonstrate that IRF-1 regulates the expression of IL-15.
NK11T Cells, NK Cells, and Intestinal IELs were Recovered
by IL-15 In Vitro. To further examine the importance of
IL-15 for maturation of NK11T cells, NK cells, and intes-
tinal IEL subsets in IRF-12/2 mice, liver MNCs and intes-
tinal IELs were isolated from these mice and cultured with
100 ng/ml mouse IL-15 for 7 d (Fig. 4 B). Recovery of
these lymphocyte subsets was observed. This suggested that
IL-15 is essential for the survival or expansion of NK11T
cells, NK cells, and intestinal IELs, and not early develop-
ment or commitment.
NK11T cells, NK cells, and intestinal IELs share cell sur-
face markers and other common features during develop-
ment. In addition to the expression and developmental re-
quirement of IL-2Rb/15Rb chain, they also express the
NK complex that encompasses NKR-P1 and Ly-49 (1, 2,
28, 29). In contrast, conventional T cells do not express
these products. Although the majority of T cells develops
in the thymus, NK cells develop normally in athymic nude
mice. The developmental origin of NK11T cells can be ei-
ther thymus dependent or independent (2, 30, 31). Thymus-
independent development of intestinal CD8-a/a1 T cells has
been clearly demonstrated to occur (8). Thus, NK11T cells
and intestinal CD8-a/a1 T cells are related to the NK lin-
eage and can be distinguished from mainstream T cells. Our
results demonstrate that IRF-1 controls the expression of
IL-15, which is likely to be important for the maturation of the
related NK11T cell, NK cell, and CD8-a/a1 IEL lineages.
Table 2. Intestinal and Thymic T Cell Subsets in IRF-12/2 Mice
Mice
Intestine Thymus*
CD8-a/a1 CD8-a/b1 TCR-a/b1 TCR-g/d1 TCR-g/d1
IRF-11/1 42.5 6 4.3 7.5 6 3.0 26.7 6 2.6 34.7 6 4.0 9.3 6 0.5
IRF-11/2 27.0 6 2.6 10.5 6 2.3 29.5 6 3.6 21.0 6 4.4 10.7 6 1.8
IRF-12/2 5.0 6 3.4 3.2 6 1.7 15.8 6 8.9 4.6 6 2.8 9.6 6 0.8
Four mice in each group were individually analyzed.
*Total thymocytes were stained with GK1.5-FITC (anti-CD4), GL-3-PE (anti–TCR-g/d), and 53.6.7-biotin (anti-CD8) plus streptavidin 670.
TCR-g/d1 cells were analyzed on gated double-negative (CD4282) thymocytes.
Figure 4. Impaired lineage
development correlates with the
absence of IL-15. (A) Limited
IL-15 expression in the absence
of IRF-1. BM cells were isolated
from IRF-12/2 mice or control
wild-type (WT) mice. Total
RNA was extracted from un-
treated BM cells or BM cells cul-
tured for 6 h in the presence of
LPS (30 mg/ml) and IFN-g (100
U/ml). Northern blot analysis
was performed using IL-15
cDNA and b-actin probes. (B)
IL-15 induces the expansion of
NK11T cells, NK cells, and IEL
subsets. Liver MNCs and intesti-
nal IELs were isolated from IRF-
12/2 mice and cultured with 100
ng/ml mouse IL-15 for 7 d.971 Ohteki et al. Brief Definitive Report
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